Health Care: Drugs

Bristol-Myers Squibb Company (BMY: NYSE)

$74.81 0.15 | 0.2%
07/29/16 - 04:00 PM ET
Company Income Statement
Dec 2015 Dec 2014 Dec 2013 Dec 2012
Sales 16.56B 15.88B 16.39B 17.62B
Cost of Sales 3.53B 3.46B 3.86B 3.93B
Gross Operating Profit 13.03B 12.41B 12.53B 13.69B
Selling, General, and Administrative Expenses 4.84B 4.09B 4.08B 4.22B
Research & Development 5.92B 4.53B 3.73B 3.90B
Operating Income before D & A (EBITDA) 2.27B 3.06B 3.86B 4.77B
Depreciation & Amortization 376.00M 467.00M 763.00M 681.00M
Interest Income 0.00 0.00 0.00 0.00
Other Income - Net 288.00M -114.00M -172.00M 79.00M
Special Income / Charges 0.00 0.00 0.00 -1.83B
Total Income Before Interest Expenses (EBIT) 2.26B 2.58B 3.09B 2.52B
Interest Expense 184.00M 203.00M 199.00M 182.00M
Pre-Tax Income 2.08B 2.38B 2.89B 2.34B
Income Taxes 446.00M 352.00M 311.00M -161.00M
Minority Interest 66.00M 25.00M 17.00M 541.00M
Net Income From Continuing Operations 1.63B 2.03B 2.58B 2.50B
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations 1.63B 2.03B 2.58B 2.50B
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income 1.56B 2.00B 2.56B 1.96B
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
1.63B 2.03B 2.58B 4.33B
Preferred Dividends
Net Income Available To Common 1.63B 2.03B 2.58B 2.50B
Basic EPS from Continuing Ops. 0.94 1.21 1.56 1.17
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations 0.94 1.21 1.56 1.17
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total 0.94 1.21 1.56 1.17
Basic Normalized Net Income/Share 0.94 1.21 1.56 2.03
EPS fr Continuing Ops. 0.93 1.20 1.54 1.16
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. 0.93 1.20 1.54 1.16
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total 0.93 1.20 1.54 1.16
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
0.93 1.20 1.54 2.01
Dividends Paid per Share 1.49 1.45 1.76 1.36

Portfolios with BMY

Latest BMY Headlines from TheStreet

More Financial News for BMY

Press Releases for BMY

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter